Literature DB >> 31724222

EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment.

Raimund Stein1, Guy Bogaert2, Hasan S Dogan3, Lisette Hoen4, Radim Kocvara5, Rien J M Nijman6, Josine S L T Quadackers6, Yazan F Rawashdeh7, Mesrur S Silay8, Serdar Tekgul3, Christian Radmayr9.   

Abstract

BACKGROUND: In childhood, the most common reason for a neurogenic bladder is related to spinal dysraphism, mostly myelodysplasia. AIMS: Herein, we present the EAU/ESPU guidelines in respect to the diagnostics, timetable for investigations and conservative management including clean intermittent catheterization (CIC).
MATERIAL AND METHODS: After a systematic literature review covering the period 2000 to 2017, the ESPU/EUAU guideline for neurogenic bladder underwent an update.
RESULTS: The EAU/ESPU guideline panel advocates a proactive approach. In newborns with spina bifida, CIC should be started as soon as possible after birth. In those with intrauterine closure of the defect, urodynamic studies are recommended be performed before the patient leaves the hospital. In those with closure after birth urodynamics should be done within the next 3 months. Anticholinergic medication (oxybutynin is the only well-investigated drug in this age group-dosage 0.2-0.4 mg/kg weight per day) should be applied, if the urodynamic study confirmed detrusor overactivity. Close follow-up including ultrasound, bladder diary, urinalysis, and urodynamics are necessary within the first 6 years and after that the time intervals can be prolonged, depending on the individual risk and clinical course. In all other children with the suspicion of a neurogenic bladder due to various reasons as tethered cord, inflammation, tumors, trauma, or other reasons as well as those with anorectal malformations, urodynamics-preferable video-urodynamics, should be carried out as soon as there is a suspicion of a neurogenic bladder and conservative treatment should be started soon after confirmation of the diagnosis of neurogenic bladder. With conservative treatment the upper urinary tract is preserved in up to 90%, urinary tract infections are common, but not severe, complications of CIC are quite rare and continence can be achieved at adolescence in up to 80% without further treatment. DISCUSSION AND
CONCLUSIONS: The transition into adulthood is a complicated time for both patients, their caregivers and doctors, as the patient wants to become independent from caregivers and treatment compliance is reduced. Also, transition to adult clinics for patients with neurogenic bladders is often not well-established.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  EAU/ESPU guidelinie; anticholinegics; conservative treatment; neurogenic bladder; spinal dysraphism

Year:  2019        PMID: 31724222     DOI: 10.1002/nau.24211

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  12 in total

1.  When to start clean intermittent catheterization (CIC) in children with neurogenic bladder dysfunction.

Authors:  Atila Rondon
Journal:  Int Braz J Urol       Date:  2022 Jan-Feb       Impact factor: 1.541

2.  Continence management in children with severe caudal regression syndrome: role of multidisciplinary team and long-term follow-up.

Authors:  Giacomo Esposito; Giorgia Totonelli; Barbara Daniela Iacobelli; Daniela Longo; Tamara Caldaro; Giulia Blasetti; Francesca Bevilacqua; Francesca Santato; Giulia Lucignani; Maria Laura Sollini; Carlo Efisio Marras; Pietro Bagolan; Giovanni Mosiello
Journal:  Pediatr Surg Int       Date:  2022-08-09       Impact factor: 2.003

3.  Anorectal malformation, urethral duplication, occult spinal dysraphism (ARM-UD-OSD): a challenging uncommon association.

Authors:  Federica Lena; Chiara Pellegrino; Antonio Maria Zaccara; Maria Luisa Capitanucci; Giacomo Esposito; Barbara Daniela Iacobelli; Daniela Longo; Tamara Caldaro; Diletta Bruno; Francesca Bevilacqua; Francesca Santato; Giulia Lucignani; Carlo Efisio Marras; Enrico Castelli; Pietro Bagolan; Giovanni Mosiello
Journal:  Pediatr Surg Int       Date:  2022-07-26       Impact factor: 2.003

4.  A 15-year retrospective review of urodynamic studies in children at Red Cross War Memorial Children's Hospital, Cape town, South Africa.

Authors:  Thembisile Dintle Mosalakatane; Mignon McCulloch; Peter Nourse; Ashton Coetzee; Anne Wright; Jeanette Raad; John Lazarus; Justin Howlett
Journal:  BMC Pediatr       Date:  2022-07-08       Impact factor: 2.567

5.  Activation of the TGF-β1/Smads/α-SMA pathway is related to histological and functional changes in children with neurogenic bladder.

Authors:  Xinghuan Yang; Qingsong Pu; Yibo Wen; Yi Zhao; Junkui Wang; Pengchao Xu; Yuan Ma; Erpeng Liu; Lei Lv; Jian Guo Wen
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

Review 6.  [Short version of the S2k guideline on drug therapy of neurogenic lower urinary tract dysfunction (NLUTD)].

Authors:  J Kutzenberger; A Angermund; B Domurath; S Möhr; J Pretzer; I Soljanik; R Kirschner-Hermanns
Journal:  Urologie       Date:  2022-10-21

7.  Spheroids of Bladder Smooth Muscle Cells for Bladder Tissue Engineering.

Authors:  Tim Gerwinn; Souzan Salemi; Lisa Krattiger; Daniel Eberli; Maya Horst
Journal:  Biomed Res Int       Date:  2021-11-11       Impact factor: 3.411

8.  Incidence of Urinary Tract Infections in Newborns with Spina Bifida-Is Antibiotic Prophylaxis Necessary?

Authors:  M Chad Wallis; Pangaja Paramsothy; Kimberly Newsome; Tonya Williams; Jonathan C Routh; David B Joseph; Earl Cheng; Duong Tu; J Chris Austin; Stacy T Tanaka; William O Walker; Kathryn A Smith; Michelle A Baum; John S Wiener
Journal:  J Urol       Date:  2021-03-08       Impact factor: 7.600

9.  Urological Evaluation of Tethered Cord Syndrome.

Authors:  Kwanjin Park
Journal:  J Korean Neurosurg Soc       Date:  2020-05-01

Review 10.  Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment.

Authors:  Cristian Sager; Ubirajara Barroso; José Murillo Bastos; Gabriela Retamal; Edurne Ormaechea
Journal:  Int Braz J Urol       Date:  2022 Jan-Feb       Impact factor: 1.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.